1.21
0.17 (16.35%)
Previous Close | 1.04 |
Open | 1.30 |
Volume | 18,333,212 |
Avg. Volume (3M) | 3,135,633 |
Market Cap | 13,310,000 |
Price / Sales | 0.520 |
Price / Book | 2.29 |
52 Weeks Range |
Profit Margin | 9.19% |
Operating Margin (TTM) | 9.24% |
Diluted EPS (TTM) | 0.170 |
Quarterly Revenue Growth (YOY) | 58.20% |
Quarterly Earnings Growth (YOY) | 232.70% |
Total Debt/Equity (MRQ) | 43.88% |
Current Ratio (MRQ) | 2.46 |
Market Trend
Short Term | Medium Term | ||
Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
Pharmaceutical Retailers (Global) | Mixed | Mixed | |
Stock | Hong Kong Pharma Digital Techno | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 1.0 |
Technical Oscillators | 2.0 |
Average | 0.25 |
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market. |
|
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
% Held by Insiders | 68.01% |
% Held by Institutions | 0.47% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |